27 completed, 5 recruiting, 5 unknown, 2 terminated. 40 Phase 2, 6 Phase 1, 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 40 | Completed 27, Recruiting 5, Unknown 5, Terminated 2, Withdrawn 1 |
| Phase 1 | 6 | Completed 2, Unknown 2, Recruiting 1, Terminated 1 |
| Phase 3 | 4 | Completed 3, Withdrawn 1 |
Follow Motivational Interviewing: new trials by email Literature Review of Motivational Interviewing trials Research Report on Motivational Interviewing
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Psilocybin Therapy for Methamphetamine Use Disorder and HIV Psilocybin 5 mg, Psilocybin 25 mg, Motivational Support - Methamphetamine Use Disorder, Human Immunodeficiency Virus (HIV) | Phase 2 | Recruiting | Nicky Mehtani, MD, MPH | 30 | 2026-12-01 | 2026-11-09 |
| Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial IL-22, Prednisone, Acamprosate - Alcohol-associated Hepatitis | Phase 2 | Recruiting | Samer Gawrieh | 216 | 2026-01-27 | 2026-07-15 |
| Motivational Interviewing Intervention For Risky Drinking Treatment Among Indigenous Population Motivational interviewing - Alcohol Abuse | Phase 1 / Phase 2 | Unknown | Department of Public Health Medicine, MARA University of Technology | 36 | 2024-10-01 | 2024-09-04 |
| Overcoming Nicotine Dependence to Enable Quitting Nicotine Replacement Therapy (NRT) Sampling, Practice Quitting (PQ) Counseling, Motivational Interviewing (MI) Counseling - Tobacco Use, Smoking Cessation | Phase 1 / Phase 2 | Recruiting | Rush University Medical Center | 780 | 2023-03-24 | 2026-09-09 |
| Vivitrol Treatment for Cannabis Use Disorder Naltrexone 380 MG [Vivitrol], Motivational Enhancement Therapy and Cognitive Behavioral Therapy - Cannabis Use Disorder | Phase 2 | Terminated | Centre for Addiction and Mental Health | 1 | 2021-06-09 | 2025-02-07 |
| A Pilot Study of Non-invasive Brain Stimulation to Boost the Efficacy of Psychotherapy in a Community Sample of People Who Drink Alcohol High-density transcranial alternating current stimulation, Sham stimulation, Motivational interviewing - Alcohol Use Disorder | Phase 2 | Recruiting | The Mind Research Network | 75 | 2020-09-01 | 2025-05-08 |
| Motivational Enhancement Therapy to Improve Adherence to Aromatase Inhibitors Motivational enhancement therapy, Attention Control - Breast Cancer, Medication Adherence | Phase 2 / Phase 3 | Withdrawn | University of Calgary | 2020-08-01 | 2024-12-05 | |
| The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking CI-581a, CI-581b, MBRP - Alcohol Use Disorder | Phase 2 | Recruiting | New York State Psychiatric Institute | 120 | 2019-11-08 | 2023-11-07 |
| Peer MI in FQHCs for Substance-using Emerging Adults Peer-enhanced Motivational Interviewing, Motivational Interviewing, Waitlist Control - Substance Use Disorders | Phase 2 | Unknown | University of Illinois at Urbana-Champaign | 150 | 2019-08-01 | 2018-11-29 |
| Glutamatergic Modulation of Disordered Alcohol Use CI-581a, CI-581b, Motivational Enhancement Therapy (MET) - Alcohol Dependence | Phase 2 / Phase 3 | Completed | New York State Psychiatric Institute | 50 | 2015-07-01 | 2020-02-11 |
| Prevention of Drug Use in Adolescence: Intervening in Parenting Styles Motivational Interviewing for Change of Parenting Styles, Psicoeducation - Substance-Related Disorders | Phase 1 / Phase 2 | Unknown | Federal University of Health Science of Porto Alegre | 200 | 2014-08-01 | 2015-03-11 |
| Improving Adherence to Medication After Coronary Artery Bypass Surgery (CABG) in Older Adults Motivational Interviewing (MI, volitional intervention, Routine discharge counseling - Coronary Artery Bypass Grafting (CABG) Surgery | Phase 2 | Completed | Qazvin University Of Medical Sciences | 288 | 2014-03-01 | 2023-01-11 |
| Motivational Interviewing to Increase Parent Engagement in Preventive Parenting Programming Motivational Interviewing, Anticipatory Guidance on Child Development - Behavior Problems, Parent-Child Relations | Phase 2 | Completed | University of Michigan | 112 | 2013-09-01 | 2015-12-02 |
| Motivational Incentives to Reduce Secondhand Smoke in NICU Infants' Homes Motivational Interviewing plus Incentives, Conventional Care (CC) - Exposure to Secondhand Smoke in Neonatal Infants | Phase 2 | Completed | The University of Texas Health Science Center, Houston | 360 | 2012-08-01 | 2018-05-14 |
| Vet-Harts Pilot Intervention for Veterans With Coronary Heart Disease Motivational Interview - Heart Disease | Phase 2 | Completed | VA Office of Research and Development | 12 | 2012-04-30 | 2018-12-24 |
| Efficacy Trial of Warrior Check-Up Motivational Enhancement Therapy, Education - Alcohol Abuse, Alcohol Dependence | Phase 2 | Completed | University of Washington | 242 | 2010-10-01 | 2015-05-27 |
| Brief Intervention for Problem Drinking and Partner Violence Motivational Enhancement Therapy - Domestic Violence, Alcohol Abuse | Phase 2 | Completed | University of Pennsylvania | 600 | 2010-09-01 | 2016-08-22 |
| Brief Intervention to Prevent Poor Psychosocial Outcomes in Living Donors Motivational Interviewing, Healthy Lifestyles Education - Living Donation | Phase 2 | Completed | University of Pittsburgh | 113 | 2010-03-01 | 2022-03-02 |
| The Impact of Psychopathic Traits on the Efficacy of a Substance Use Intervention motivational enhancement therapy, standard care - Substance Use, Psychopathy | Phase 2 | Completed | University of Rochester | 105 | 2009-08-01 | 2016-12-12 |
| Benefits Counseling to Preserve Function Among Disability Applicants Benefits Counseling, VA Orientation - Veterans' Disability Claims | Phase 2 | Completed | VA Office of Research and Development | 92 | 2008-12-01 | 2016-03-11 |
Showing 20 of 40. Sign in to see all of them.
Substance-Related Disorders (11) · Alcoholism (7) · Marijuana Abuse (3) · Mental Disorders (3) · Smoking (3) · Acquired Immunodeficiency Syndrome (2) · Diabetes Mellitus (2) · HIV Infections (2) · Obesity (2) · Smoking Cessation (2) · Acute Coronary Syndrome (1) · Alcohol Drinking (1) · Amphetamine-Related Disorders (1) · Antisocial Personality Disorder (1) · Attention Deficit Disorder with Hyperactivity (1)
Medical University of South Carolina (2) · New York State Psychiatric Institute (2) · The University of Texas Health Science Center, Houston (2) · University of Pennsylvania (2) · University of Washington (2) · VA Office of Research and Development (2) · Boston Children's Hospital (1) · Boston Medical Center (1) · Cardiff University (1) · Centre for Addiction and Mental Health (1) · Department of Public Health Medicine, MARA University of Technology (1) · Federal University of Health Science of Porto Alegre (1) · Massachusetts General Hospital (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · National Institute on Drug Abuse (NIDA) (1)
United States (31) · Canada (2) · Brazil (1) · Iran (1) · Malaysia (1) · Mexico (1) · United Kingdom (1)
Aimee L McRae, PharmD (2) · Elias Dakwar, MD (2) · Adeline Nyamathi, PhD (1) · Amanda Mathew, PhD (1) · Amir H Pakpour, PhD (1) · Angela Stotts, PhD (1) · Bernard Le Foll, MD,PhD,MCFP (1) · Deborah Moss, MD, MPH (1) · Denise D Walker, PhD (1) · Douglas C Smith, PhD (1) · Edmond Wickham, M.D. (1) · Elyse Park, Ph.D. (1) · Hans-Juergen Rumpf, Ph.D. (1) · James R. McKay, Ph.D (1) · Janet Audrain-McGovern, Ph.D (1)
PMID 16168872, PMID 16435644, PMID 16443391, PMID 16570748, PMID 16818482, PMID 17063017, PMID 17332036, PMID 17352592, PMID 17518963, PMID 17615014, PMID 17634300, PMID 17682259, PMID 18039285, PMID 18205641, PMID 18254414, PMID 18445798, PMID 18474051, PMID 18594082, PMID 18767507, PMID 19133895, PMID 19186773, PMID 19192101, PMID 19197261, PMID 19329463, PMID 19571052, PMID 20437303, PMID 21512406, PMID 21916925, PMID 21939867, PMID 22891807, PMID 23785451, PMID 23924065, PMID 24090622, PMID 24212451, PMID 24424425, PMID 25082304, PMID 25890676, PMID 26241598, PMID 26727409, PMID 28004259, PMID 29489073, PMID 30126411, PMID 31786934, PMID 31870605, PMID 31894995, PMID 32608505
1DP2DA066200 (1), K23DA015144 (1), K23DA015440 (1), K23DA027720 (1), P30GM122734 (1), P50DA009262 (1), R01AA027509 (1), R01DA013549 (1), R01DA014296 (1), R01DA015690 (1), R01DA023877 (1), R01DK054041 (1), R01HL107404 (1), R03CA130722 (1), R21AA023010 (1)